504-400-0439 info@research.works
  • Employment & Internship Opportunities
Women Under Study
  • Home
  • Research Works
    • How Research Works
    • Why Research Works
    • How Research Works For Me
  • About
    • Philosophy & Mission
    • Meet The Team
  • Enrolling Studies
  • Resources
    • Patients
    • Sponsors
    • In the know
  • Contact
Select Page

AbbVie Submits NDA for Endometriosis Treatment Elagolix

by Kaye Doiron | Jan 20, 2018 | Uncategorized

Read the article here: https://goo.gl/6D2RTj
NOLA Research Works and Women Under Study is currently conducting this clinical trial.
We have been working with ABBVIE on this compound since 2010 and are so excited to hear that women who suffer from Endometriosis may soon have a new treatment available!

Recent Posts

  • Crohn’s Disease: What Are The Symptoms And Is There A Cure?
  • Do feminine hygiene products actually lead to a higher risk of infection?
  • Support Nola Research Works for IBD at the New Orleans Take Steps for Crohn’s & Colitis on 04/21/2018!
  • Study Shows Increased Risk of Uterine Fibroids in African-American Women With a Common Form of Hair Loss
  • What is cervical endometriosis?

Archives

  • April 2018
  • March 2018
  • January 2018

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org